Derivative Instruments and Hedging Activities (Tables)
 9 Months Ended
Feb. 28, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Summary Existing Swap Agreements
The table below summarizes existing swap agreements at February 28, 2014 and May 31, 2013:
 
(U.S. dollars and euros in millions)
 
 
 
 
 
Fair Value at
 
Fair Value at
 
 
 
 
Notional
 
 
 
 
 
February 28, 2014
 
May 31, 2013
Structure
 
Currency
 
Amount   
 
Effective Date
 
Termination Date
 
Asset (Liability)
 
Asset (Liability)
5 years
 
EUR(1)
 
€
200.0

 
September 25, 2012
 
September 25, 2017
 
—

 
(11.3
)
5 years
 
EUR(1)
 
200.0

 
September 25, 2012
 
September 25, 2017
 
—

 
(11.1
)
5 years
 
USD
 
$
325.0

 
December 26, 2008
 
December 25, 2013
 
—

 
(3.8
)
5 years
 
USD
 
195.0

 
September 25, 2009
 
September 25, 2014
 
(3.0
)
 
(6.7
)
2 years
 
USD
 
190.0

 
March 25, 2013
 
March 25, 2015
 
(1.3
)
 
(1.7
)
3 years
 
USD
 
270.0

 
December 27, 2013
 
September 25, 2016
 
(6.2
)
 
(5.2
)
5 years
 
USD
 
350.0

 
September 25, 2012
 
September 25, 2017
 
(6.1
)
 
(7.5
)
5 years
 
USD
 
350.0

 
September 25, 2012
 
September 25, 2017
 
(6.0
)
 
(7.4
)
Credit valuation adjustment
 
 
 
0.2

 
0.6

Total interest rate instruments
 
 
 
$
(22.4
)
 
$
(54.1
)
(1)
The euro interest rate swaps were terminated during the second quarter of fiscal year 2014.
Schedule of Interest Rate Swap
The tables below summarize the effective portion and ineffective portion of the Company’s interest rate swaps for the nine months ended February 28, 2014 and February 28, 2013:
 
(in millions)
 
Three Months Ended
 
Nine Months Ended
Derivatives in cash flow hedging relationship
 
February 28, 2014
 
February 28, 2013
 
February 28, 2014
 
February 28, 2013
Interest rate swaps:
 
 
 
 
 
 
 
 
Amount of gain (loss) recognized in OCI
 
$
5.5

 
$
10.7

 
$
31.7

 
$
9.5

Amount of (gain) loss reclassified from accumulated OCI into interest expense (effective portion)
 
6.2

 
9.0

 
20.5

 
40.4

Amount (gain) loss recognized in other income (expense) (ineffective portion and amount excluded from effectiveness testing)
 
—

 
—

 
21.8

 
—